Management of septic shock in childhood

EMA - Emergency Medicine Australasia

Volumn 16, Issue 2, 2004, Pages 125-134

  Sparrow, Annie ^a,c   Willis, Frank ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c Paediatric Emergency Medicine

Author keywords

Antibiotics; Fluids; Resuscitation; Sepsis; Shock

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; FLUCLOXACILLIN; METRONIDAZOLE; VANCOMYCIN;

ANTIBIOTIC THERAPY; CHILD; CHILDHOOD MORTALITY; HUMAN; INFLAMMATION; MORBIDITY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPTIC SHOCK; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 2342515276     PISSN: 17426731     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-6723.2004.00564.x     Document Type: Review

References (71)

1. Shoemaker WC. Tissue perfusion and oxygenation: a primary problem in acute circulatory failure and shock states. Crit. Care Med. 1991; 19: 595-6.
2. Advanced Life Support Group. Advanced paediatric life support, 3rd edn. London: BMJ Publishing Group 2001.
3. Bone RC. The pathogenesis of sepsis. Ann. Intern. Med. 1991; 115: 457-69.
4. Hay WW, Groothuis JR, Hayward AR, Levin MJ, eds. Current paediatric diagnosis and treatment, 12th edn. Norwalk: Appleton and Lange, 1995.
5. Morton NS. Paediatric intensive care. Oxford: Oxford University Press, 1997.
6. Rogers MC, ed. Textbook of paediatric intensive care, 3rd edn. Baltimore: Williams & Wilkins, 1996.
7. Carcillo JA. Management of pediatric septic shock. In: Holbrook PR, eds. Textbook of paediatric critical care, 1st edn. Philadelphia: W.B. Saunders Co., 1993.
8. Nadel S, Levin M, Habibi P. Treatment of meningococcal disease in childhood. In: Cartwright K, ed. Meningococcal disease. Chichester: John Wiley and Sons, 1995.
9. Levin DL, Morriss FC, eds. Essentials of paediatric intensive care, 2nd edn. New York: Churchill Livingstone, 1997.
10. Astiz ME, Rackow EC. Septic shock. Lancet 1998; 351: 1501-5.
11. Bone RC. Immunological dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 1996; 125: 60-87.
12. Nadel S, Habibi P, Levin M. Management of meningococcal septicemia. Care Critically Ill. 1995; 11: 33-8.
13. Wardle EN. New research findings in septic shock/endotoxaemia. Care Critically Ill. 1997; 13: 222-6.
14. Schexnayder SM. Pediatric septic shock. Pediatr. Rev. 1999; 209: 303-8.
15. Baines PB, Marzouk O, Thoson APJ, Sills JA, Riordan FAI, Hart CA. Endothelial cell adhesion molecules in meningococcal disease. Arch. Dis. Child 1999; 80: 74-6.
16. Repine E. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992; 399: 466-9.
17. Von Rosenstiel N, von Rosenstiel I, Adam D. Management of Sepsis and Septic Shock in Infants and Children. Paediatric Drugs 2001; 3: 9-27.
18. Vincent JL. End-points of resuscitation: arterial blood pressure, oxygen delivery, blood lactate, or ...? Intensive Care Med. 1996; 22: 3-5.
19. Cartwright K, Reilly S, White D, Stuart J. Early treatment with parenteral penicillin in meningoccoccal disease. BMJ 1992; 305: 141-3.
20. Gedde-Dahl TW, Hoiby EA, Brandtzaeg P, Eskerud JR, Bovre K, Some arguments on early hospital admission and treatment of suspected meningococcal disease cases. NIPH Ann. 1990; 67: 157-61.
21. Strang JR, Pugh EJ. Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital. BMJ 1992; 305: 141-3.
22. Pollard AJ, Britto J, Nadel S, De Munter C, Habibi P, Levin M. Emergency management of meningococcal disease [comment]. Arch. Dis. Child 2000; 82: 266.
23. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998; 316: 961-4.
24. Rackow EC, Falk JL, Fein IA et al. Fluid resuscitation in shock: a comparison of the cardiorespiratory effects of albumin, hetastarch and saline solutions in patients with hypovolemic shock. Crit. Care Med. 1983; 11: 839-50.
25. Stockwell MA, Soni N, Riley B. Colloid solutions in the critically ill. Anaesthesia 1992; 47: 3-6.
26. Nadel S, de Munter C, Britto J, Levin M, Habibi P. Albumin: saint or sinner? Arch. Dis. Child 1998; 79: 384-5.
27. Skellett S, Mayer A, Durward A, Tibby SM, Murdoch IA. Chasing the base deficit: hyperchloraemic acidosis following 0.9% saline fluid resuscitation. Arch. Dis. Child 2000; 83: 514-16.
28. Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in paediatric septic shock. JAMA 1991; 266: 1242-5.
29. Nurnberger W v. Kries R, Boehm O, Goebel U. Systemic meningococcal infection: Which children may benefit from adjuvant haemostatic therapy? Results from an observational study. Eur. J. Fediatr 1999; 158: S192-196.
30. Pollard AJ, Britto J, Nadel S, DeMunter C, Habibi P, Levin M. Emergency management of meningococcal disease. Arch. Dis. Child 1999; 80: 290-6.
31. Yamamoto LG, Yim GK, Britten AG. Rapid sequence anesthesia for emergency intubation. Pediatr. Emerg. Care 1990; 6: 200-13.
32. Lopez-Herce J, de Lucas N, Carrillo A, Bustinza A, Moral R. Surfactant treatment for acute respiratory distress syndrome. Arch. Dis. Child 1999; 80: 248-52.
33. Beca J, Butt W. Extracorporeal membrane oxygenation for refractory septic shock in children. Pediatrics 1994; 93: 726-9.
34. Champion MP, Murdoch IA, Sajjanhar T et al. Extracorporeal membrane oxygenation for refractory shock in fulminant meningococcal sepsis. Lancet 1996; 374: 201-2.
35. Goldman AP, Kerr SJ, Butt W et al. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997; 349: 466-9.
36. Hagmolen of ten Have W, Wiegman A, van den Hoek GJ, Vreede WB, Derkx HHF. Life threatening heart failure in meningococcal septic shock in children: non-invasive measurement of cardiac parameters is of important prognostic value. Eur. J. Pediatr. 2000; 159: 277-82.
37. Oh TE, ed. Intensive care manual, 4th edn. Sydney: Butterworths-Heinemann, 1996.
38. Graver J. Inotropes - an overview. Intensive Crit. Care Nurs. 1992; 8: 169-79.
39. Vincent J-L, Friedman G, Jankowski S, Zhang H. Use of vasoactive drugs in sepsis and septic shock. Balliere's Clin. Anaesthesiol 1996; 10: 265-75.
40. Ceneviva G, Paschall JA, Maffei F, Carcillo JA. Hemodynamic support in fluid-refractory septic shock. Pediatrics 1998; 102: e19.
41. Yunge M, Petros A. Angiotensin for septic shock unresponsive to noradrenaline. Arch. Dis. Child 2000; 82: 388-9.
42. Bakker J, Vincent JL. Effects of noradrenaline and dobutamine on oxygen transport and consumption in a dog model of endotoxic shock. Crit. Care Med. 1993; 21: 425-32.
43. Corrigan JJ, Jordan CM. Heparin therapy in septicaemia with disseminated intravascular coagulation. Effect on mortality and on correction of hemostatic defects. N. Engl. J. Med. 1970; 283: 778-82.
44. Tasker RC, Matthew DJ, Helms P, Dinwiddie R, Boyd S. Monitoring in nontraurnatic coma. Part 1: invasive intracranial measurements. Arch. Dis. Child 1988; 63: 888-94.
45. Tasker RC, Boyd S, Harden A, Matthew DJ. Monitoring in non-traumatic coma. Part 11: electroencephalography. Arch. Dis. Child 1988; 63: 895-9.
46. Chernow B. Calcium: does it have a therapeutic role in sepsis? Crit. Care Med. 1990; 18: 895-6.
47. Zaloga GP, Roberts PR. Early enteral feeding improves outcome. In: Vincent, JL, ed. Yearbook of intensive care and emergency medicine. Berlin: Springer-Verlag, 1997; 701-4.
48. Hatherill M, Tibby S, Hilliard T, Turner C, Murdoch IA. Adrenal insufficiency in septic shock. Arch. Dis. Child 1999; 80: 51-5.
49. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 1987; 317: 653-8.
50. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit. Care Med. 1995; 23: 1294-303.
51. Riordan F, Thompson A, Ratcliff J, Sills J, Diver M, Hart A. Admission cortisol and adrenocorticotrophic hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency? Crit. Care Med. 1999; 27: 2257-61.
52. Cronin L, Cook D, Carlet J et al. Corticosteroid treatment for sepsis. A critical appraisal and meta-analysis of the literature. Crit. Care Med. 1995; 23: 1430-9.
53. Briegel J, Forst H, Haller M et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit. Care Med. 1999; 27: 723-32.
54. Derkx B, Wittes J, McCloskey R, European Pediatric Meningococcal Septic Shock Trial Study Group. Randomized placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. Clin. Infect. Dis. 1999; 28: 770-7.
55. Giroir BP, Quint PA, Barton P et al. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal-permeability-increasing protein in children with severe meningococcal sepsis. Lancet 1997; 350: 1439-43.
56. van Deuren M, Santman FW, van Dalen R et al. Plasma and whole blood exchange in meningococcal sepsis. Clin. Infect. Dis. 1992; 15: 424-30.
57. Hjorth V, Stenlund G. Plasmapheresis as part of the treatment for septic shock. Scand. J. Infect. Dis. 2000; 32: 511-14.
58. Pearson G, Khandelwal PC, Naqvi N. Early filtration in meningococcal septic shock? Arch. Dis. Child 2000; 83: 508-9.
59. Reeves JH, Butt W, Shann F et al. Continuous plasmafiltration in sepsis syndrome. Crit. Care Med. 1999; 27: 2096-104.
60. Bernard GR, Vincent JL, Laterre PF et al. Efficacy and safety of human activated protein C for severe sepsis. N. Engl. J. Med. 2001; 344: 699-709.
61. Bernard GR. Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Crit. Care Med. 2003; 31: S85-93.
62. Eichacker PQ, Natanson C. Recombinant human activated protein C in sepsis. Inconsistent trial results, and unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials. Crit. Care Med. 2003; 31: S94-6.
63. Eley B, Levin M. Purpura fulminans. In: Harper J, Oranje A, Prose N, eds. Textbook of pediatric dermatology. Malden: Blackwell Science, 2000; 1574-87.
64. Faust SN, Heyderman RS, Levin M. Disseminated intravascular coagulation and purpura fulminans secondary to infection. Baillieres Best Pract. Res. Clin. Haematol. 2000; 13: 179-97.
65. Faust SN, Levin M, Harrison OB et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N. Engl. J. Med. 2001; 345: 408-16.
66. Smith OP, White B, Vaughan D et al. Use of protein C concentrate, heparin and haemofiltration in meningococcus-induced purpura fulminans. Lancet 1997; 350: 1590-3.
67. White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP. An open-label study of the role of adjuvant hemostatic support with protein C replacment therapy in purpura fulminans-associated meningococcaemia. Blood 2000; 96: 3719-24.
68. Rintala E, Seppala OP, Kotilainen P, Pettila V, Rasi V, Protein C in the treatment of coagulaopathy in meningococcal disease. Crit. Care Med. 1998; 26: 965-8.
69. Leclerc F, Cremer R, Leteurtre S, Martinot A, Fourier C. Protein C concentrate and recombinant tissue plasminogen activator in meningococcal septic shock. Crit. Care Med. 2000; 28: 1694-5.
70. Isaacs D, Barfield CP, Grimwood K, McPhee AJ, Minutillo C, Tudehope DI. for the Australian Study Group for Neonatal Infections. Systemic bacterial and fungal infections in infants in Australian neonatal units. Med. J. Aust. 1995; 162: 198-201.
71. Therapeutic Guidelines Ltd. Therapeutic Guidelines: Antibiotic, Version 12. Melbourne: Therapeutic Guidelines Limited, 2003.